Online First Archives - Medical Conferences

Single-dosed exa-cel leads to early and durable increase of foetal haemoglobin

Presented By

Prof. Franco Locatelli, University of Pavia, Italy

Trial

Phase 2, CLIMB THAL-111, CLIMB SCD-121

Conference

EHA 2022

15 June, 2022 11:29

Triplet therapy plus early ASCT improves PFS in newly diagnosed multiple myeloma versus triplet therapy alone

Presented By

Dr Paul Richardson, Dana-Farber Cancer Institute, MA, USA

Trial

Phase 3, DETERMINATION

Conference

EHA 2022

15 June, 2022 11:27

Triple-therapy improves PFS in fit, previously untreated CLL patients

Presented By

Prof. Barbara Eichhorst, University Hospital Cologne, Germany

Trial

Phase 3, GAIA/CLL13

Conference

EHA 2022

15 June, 2022 11:26

DA-EPOCH-R is equally effective but less toxic compared with CODOX-M/R-IVAX in patients with high-risk Burkitt lymphoma

Presented By

Prof. Martine Chamuleau, Amsterdam UMC, the Netherlands

Conference

EHA 2022

15 June, 2022 11:24

PI3Kδ inhibitor leniolisib improves symptoms in patients with APDS/PASLI

Presented By

Dr Koneti Rao, National Institutes of Health, MD, USA

Conference

EHA 2022

15 June, 2022 11:23

Axi-cel superior over standard-of-care in older patients with relapsed/refractory large B-cell lymphoma

Presented By

Dr Anna Sureda, University of Barcelona, Spain

Trial

Phase 3, ZUMA-7

Conference

EHA 2022

14 June, 2022 11:12

Quizartinib prolongs survival of newly diagnosed FLT3-ITD-mutated AML patients

Presented By

Dr Harry Erba, Duke Cancer Institute, NC, USA

Trial

Phase 3, QuANTUM-First

Conference

EHA 2022

14 June, 2022 11:10

Transfusion-dependent β-thalassemia patients continue to benefit from luspatercept after 3 years of treatment.

Presented By

Prof. Maria Capellini, University of Milan, Italy

Trial

Phase 3, BELIEVE

Conference

EHA 2022

14 June, 2022 11:07

New subtypes of oncogenic deregulation in childhood T-ALL

Presented By

Dr Petri Pölönen, St. Jude Children's Research Hospital, TN, USA

Conference

EHA 2022

14 June, 2022 11:04

No survival benefit of CPX-351 over FLAG-Ida in AML patients with adverse cytogenetics

Presented By

Prof. Nigel Russell, Guy's and St Thomas' NHS Foundation Trust, UK

Trial

Phase 3, AML19

Conference

EHA 2022

14 June, 2022 11:02

Pan-clonal score predicts first-line treatment response in AML

Presented By

Dr Yannik Severin, ETH Zurich, Switzerland

Conference

EHA 2022

13 June, 2022 12:03

Post-transplant carfilzomib, lenalidomide, and dexamethasone outperforms post-transplant lenalidomide in multiple myeloma

Presented By

Dr Dominik Dytfeld, Poznan University of Medical Sciences, Poland

Trial

Phase 3, ATLAS

Conference

EHA 2022

13 June, 2022 12:02

Abscopal response in patients with relapsed or refractory Hodgkin lymphoma who failed on anti-PD treatment

Presented By

Dr Paul Bröckelmann, University Hospital of Cologne, Germany

Trial

Phase 2, AERN

Conference

EHA 2022

13 June, 2022 12:00

Momelotinib induces a rapid and sustained improvement in haemoglobin levels in patients with myelofibrosis

Presented By

Dr Srdan Verstovsek, University of Texas MD Anderson Cancer Center, TX, USA

Trial

Phase 3, MOMENTUM

Conference

EHA 2022

13 June, 2022 11:58

Caplacizumab is safe and effective in patients with iTTP, also in the long term

Presented By

Prof. Marie Scully, University College London Hospitals, UK

Trial

Phase 3, post-HERCULES

Conference

EHA 2022

13 June, 2022 11:56

Treatment with bimekizumab beneficial in psoriatic arthritis

Presented By

Prof. Iain McInnes, Glasgow University, UK

Trial

Phase 3, BE OPTIMAL

Conference

EULAR 2022

9 June, 2022 14:41

IL-6 inhibition successful in treating polymyalgia rheumatica

Presented By

Prof. Bhaskar Dasgupta, Anglia Ruskin University, UK

Trial

Phase 3, SAPHYR

Conference

EULAR 2022

9 June, 2022 14:39

High morbidity in pregnant lupus patients and their unborn children

Presented By

Prof. Bella Mehta, Weill Cornell Medical College, USA

Conference

EULAR 2022

9 June, 2022 14:37

Sexual dysfunction prevalent in RA and PsA patients

Presented By

Dr Carlos Valera-Ribera, Doctor Peset University Hospital, Spain

Conference

EULAR 2022

9 June, 2022 14:35

Fitness trackers reveal a low level of physical activity in patients with musculoskeletal disease

Presented By

Honoria Ocagli, University of Padova, Italy

Conference

EULAR 2022

9 June, 2022 14:32

Spectacular results for dostarlimab in mismatch repair deficient rectal cancer

Presented By

Dr Andrea Cercek, Memorial Sloan Kettering Cancer Center, NY, USA

Conference

ASCO 2022

9 June, 2022 12:42

Panitumumab beats bevacizumab in RAS wild-type left-sided metastatic colorectal cancer

Presented By

Dr Takayuki Yoshino, National Cancer Center Hospital East, Japan

Trial

Phase 3, PARADIGM

Conference

ASCO 2022

9 June, 2022 12:38

Ifosfamide is likely to be the go-to therapy in recurrent Ewing sarcoma

Presented By

Dr Martin McCabe, University of Manchester, UK

Trial

Phase 3, rEECur

Conference

ASCO 2022

9 June, 2022 12:37

Radiotherapy may be omitted in many breast cancer patients

Presented By

Prof. Timothy Whelan, McMaster University, Canada

Trial

LUMINA

Conference

ASCO 2022

9 June, 2022 12:36

Dabrafenib plus trametinib candidates for standard-of-care in BRAF V600-mutated paediatric low-grade glioma

Presented By

Prof. Eric Bouffet, University of Toronto, Canada

Conference

ASCO 2022

9 June, 2022 12:34

Trabectedin not superior to chemotherapy in recurrent epithelial ovarian cancer

Presented By

Dr Domenica Lorusso, Catholic University of Sacred Heart, Italy

Trial

Phase 3, MIT023

Conference

ASCO 2022

9 June, 2022 12:32

Global safety report data show more VTE events on JAK inhibition in RA

Presented By

Prof. Adeline Ruyssen-Witrand, University Hospital of Toulouse III Paul Sabatier, France

Conference

EULAR 2022

8 June, 2022 11:58

TYK2 inhibition: A rising star in lupus therapy?

Presented By

Prof. Eric Morand, Monash University, Australia

Trial

Phase 2, PAISLEY

Conference

EULAR 2022

8 June, 2022 11:55

Steep increase of mortality in RA patients with comorbid depression

Presented By

Dr Jens Kristian Pedersen, Odense University Hospital, Denmark

Conference

EULAR 2022

8 June, 2022 11:52

Antifibrotic therapy also effective in patients with negative prognostic factors for lung function decline

Presented By

Prof. Christopher Denton, University College London, UK

Trial

SENSCIS

Conference

EULAR 2022

8 June, 2022 11:49

Tailored exercise needed for COPD patients

Presented By

Prof. Andre Nyberg, Umea University, Sweden

Conference

NLC 2022

8 June, 2022 11:48

EILO is often misdiagnosed

Presented By

Dr Emil Walsted, Bispebjerg Hospital, Denmark

Conference

NLC 2022

8 June, 2022 11:47

Vaping amongst adolescents: a worrying trend

Presented By

Dr Anu Linnansaari, University of Tampere, Finland

Conference

NLC 2022

8 June, 2022 11:46

Link between asthma and decreased fertility is being unravelled in the PRO-ART study

Presented By

Dr Anne Hansen, Copenhagen University Hospital Hvidovre, Denmark

Trial

PRO-ART

Conference

NLC 2022

8 June, 2022 11:45

Identification of latent TB infection key to curb spread of the disease

Presented By

Prof. Tuula Vasankari, University of Turku, Finland

Conference

NLC 2022

8 June, 2022 11:43

Worse psychological symptoms in IBD patients with concomitant fibromyalgia

Presented By

Dr Laura Guida, Luigi Sacco University Hospital, Italy

Conference

EULAR 2022

8 June, 2022 11:41

DESTINY-Breast04: Practice-changing results of T-DXd in HER2-low breast cancer

Presented By

Dr Shanu Modi, Memorial Sloan Kettering Cancer Center, NY, USA

Trial

Phase 3, DESTINY-Breast04

Conference

ASCO 2022

8 June, 2022 10:59

KEYNOTE-716: First results on distant metastasis-free survival in stage II melanoma

Presented By

Prof. Georgina Long, The University of Sydney, Australia

Trial

Phase 3, KEYNOTE-716

Conference

ASCO 2022

8 June, 2022 10:57

ATHENA-MONO: primary results of rucaparib in ovarian cancer

Presented By

Prof. Bradley Monk, University of Arizona, AZ, USA

Trial

Phase 3, ATHENA

Conference

ASCO 2022

8 June, 2022 10:54

Autologous stem cell transplantation plus RVd improves PFS in newly diagnosed multiple myeloma

Presented By

Prof. Paul Richardson, Harvard Medical School, MA, USA

Trial

Phase 3, DETERMINATION

Conference

ASCO 2022

8 June, 2022 10:49

PALOMA-2: shaky OS results of palbociclib in ER-positive/HER2-negative breast cancer

Presented By

Prof. Richard Finn, UCLA David Geffen School of Medicine, CA, USA

Trial

Phase 3, PALOMA-2

Conference

ASCO 2022

8 June, 2022 10:47

SKYSCRAPER-02: additional tiragolumab does not help patients with untreated SCLC

Presented By

Dr Charles Rudin, Memorial Sloan Kettering Cancer Center, NY, USA

Trial

Phase 3, SKYSCRAPER-02

Conference

ASCO 2022

8 June, 2022 10:45

JAK inhibitor shows to be effective in non-radiographic axSpA

Presented By

Prof. Filip van den Bosch, Ghent University, Belgium

Trial

Phase 3, SELECT-AXIS-2

Conference

EULAR 2022

7 June, 2022 15:38

Tapering TNF blockers in axSpA and psoriatic arthritis: a successful approach

Presented By

Dr Celia Michielsens, Radboud Institute for Health Sciences, the Netherlands

Conference

EULAR 2022

7 June, 2022 15:36

Baricitinib shows great potential in juvenile idiopathic arthritis

Presented By

Prof. Athimalaipet Ramanan, Bristol Medical School, UK

Trial

Phase 3, JUVE-BASIS

Conference

EULAR 2022

7 June, 2022 15:33

Unexpected comorbidity in patients with knee and hip osteoarthritis

Presented By

Dr Anne Kamps, Erasmus University Medical Center, the Netherlands

Trial

Cohort study

Conference

EULAR 2022

7 June, 2022 15:31

RA: Several risk factors identified for incident dementia

Presented By

Dr Elena Myasoedova, Mayo Clinic, USA

Trial

Cohort study

Conference

EULAR 2022

7 June, 2022 15:25

SHINE: novel first-line treatment option for MCL

Presented By

Dr Michael Wang, Anderson Cancer Center, TX, USA

Trial

Phase 3, SHINE

Conference

ASCO 2022

7 June, 2022 12:28

TROPiCS-02: sacituzumab govitecan meets primary endpoint

Presented By

Prof. Hope Rugo, University of California San Francisco, CA, USA

Trial

Phase 3, TROPiCS-02

Conference

ASCO 2022

7 June, 2022 12:26

CALYPSO: exploratory treatment options fail in ccRCC

Presented By

Prof. Thomas Powles, University of London, UK

Trial

Phase 2, CALYPSO

Conference

ASCO 2022

7 June, 2022 12:24

Novel treatment option for KRAS wild-type pancreatic cancer

Presented By

Prof. Thomas Seufferlein, Ulm University Hospital, Germany

Trial

Phase 3, NOTABLE

Conference

ASCO 2022

7 June, 2022 12:22

Adjuvant everolimus may benefit high-risk RCC

Expert

Dr Christopher W. Ryan, Oregon Health & Science University, OR, USA

Trial

Phase 3, EVEREST

Conference

ASCO 2022

7 June, 2022 12:19

New standard-of-care for cisplatin-ineligible LAHNSCC

Presented By

Prof. Vanita Noronha, Tata Memorial Hospital, India

Conference

ASCO 2022

7 June, 2022 12:17

Could thoracic ultrasound be a new way to diagnose RA-ILD?

Presented By

Dr Bjørk Sofíudóttir, University of South Denmark, Denmark

Trial

AURORA

Conference

NLC 2022

7 June, 2022 10:35

Physical activity for asthma patients improves asthma control

Presented By

Dr Morten Hostrup, University of Copenhagen, Denmark

Conference

NLC 2022

7 June, 2022 10:34

Social distancing led to reduced number of exacerbations in bronchiectasis patients

Conference

NLC 2022

7 June, 2022 10:33

No oral corticosteroids before a confirmed diagnosis of ILD

Conference

NLC 2022

7 June, 2022 10:31

Lung cancer screening in Denmark

Presented By

Dr Zaigham Saghir, University of Copenhagen, Denmark

Conference

NLC 2022

7 June, 2022 10:30

HFpEF burden in patients with COVID-19 calls for action

Presented By

Ms Jieling Chen, Gaithersburg, USA

Conference

HFA 2022

25 May, 2022 14:12

Delayed initiation of novel GDMTs may wreak havoc on HF patients

Presented By

Dr Gianluigi Savarese, Karolinska University Hospital, Sweden

Trial

EVOLUTION-HF

Conference

HFA 2022

25 May, 2022 14:09

EMPULSE: empagliflozin delivers rapid and clinically meaningful decongestion

Presented By

Prof. Piotr Ponikowski, Medical University of Wroclaw, Poland

Trial

Phase 3, EMPULSE

Conference

HFA 2022

25 May, 2022 14:03

DAPA-VO2: Rapid effect of dapagliflozin on Peak VO2 in stable HFrEF

Presented By

Dr Julio Núñez, University of Valencia, Spain

Trial

DAPA-VO2

Conference

HFA 2022

25 May, 2022 14:00

FIDELITY: Cardiorenal benefits of finerenone, regardless of LVH status

Presented By

Prof. Gerasimos Filippatos, Attikon University Hospital, Greece

Trial

FIDELITY

Conference

HFA 2022

25 May, 2022 13:55

REBALANCE-HF: Encouraging results of GSN ablation in HFpEF

Presented By

Dr Marat Fudim, Duke Cardiology Clinic, USA

Trial

REBALANCE-HF

Conference

HFA 2022

24 May, 2022 11:21

Dapagliflozin performs consistently across LVEF in HF

Presented By

Dr Mikhail Kosiborod, St. Luke’s Hospital, USA

Trial

DEFINE-HF; PRESERVED-HF

Conference

HFA 2022

24 May, 2022 11:15

First non-adrenergic drug to show benefit on BP in pre-cardiogenic shock

Presented By

Prof. Marco Metra, University of Brescia, Italy

Trial

SEISMiC

Conference

HFA 2022

24 May, 2022 11:12

HELIOS-A: Vutrisiran meets exploratory endpoints

Presented By

Dr Pablo García-Pavía, Hospital Universitario Puerta de Hierro Majadahonda, Spain

Trial

Phase 3, HELIOS-A

Conference

HFA 2022

24 May, 2022 11:09

DAPA-HF: Dapagliflozin safe and efficacious in frail patients

Presented By

Dr Jawad Haider Butt, Copenhagen University Hospital, Denmark

Trial

DAPA-HF

Conference

HFA 2022

23 May, 2022 15:53

Cardiac contractility modulation therapy promising for patients with HFpEF

Presented By

Prof. Cecilia Linde, Karolinska University Hospital, Sweden

Trial

CCM-HFpEF

Conference

HFA 2022

23 May, 2022 15:50

EMPEROR-Preserved: Empagliflozin stable across age groups

Presented By

Prof. Michael Böhm, University of the Saarland, Germany

Trial

EMPEROR-Preserved

Conference

HFA 2022

23 May, 2022 15:45

Should ATTR-CM be added to differential diagnosis of patients with HF?

Presented By

Dr Rocío Ruiz Hueso, University Hospital of Virgen Macarena, Spain

Conference

HFA 2022

23 May, 2022 15:42

GALACTIC-HF: Omecamtiv mecarbil option for HFrEF patients with low SBP

Presented By

Prof. Marco Metra, University of Brescia, Italy

Trial

GALACTIC-HF

Conference

HFA 2022

23 May, 2022 15:39

New guidelines for IPF and PPF

Presented By

Dr Elisabeth Renzoni, Royal Brompton Hospital, UK

Conference

ATS 2022

19 May, 2022 12:37

Is avacopan better than prednisone for respiratory ANCA-associated vasculitis outcomes?

Presented By

Prof. Ulrich Specks, Mayo Clinic, MN, USA

Trial

Phase 3, ADVOCATE

Conference

ATS 2022

19 May, 2022 12:35

Novel P2X3 antagonist can SOOTHE chronic cough

Presented By

Prof. Jaclyn Smith, University of Manchester, UK

Trial

Phase 2, SOOTHE

Conference

ATS 2022

19 May, 2022 12:34

PAGANINI phase 2b data promising for eliapixant

Presented By

Prof. Peter Dicpinigaitis, Albert Einstein College of Medicine, NY, USA

Trial

Phase 2, PAGANINI

Conference

ATS 2022

19 May, 2022 12:32

POISE-3: Tranexamic acid for non-cardiac surgery

Presented By

Prof. Philip Devereaux, McMaster University, Canada

Trial

Phase 3, POISE-3

Conference

ATS 2022

19 May, 2022 12:31

Colistimethate sodium PROMISing for non-cystic fibrosis bronchiectasis

Presented By

Dr Charles Haworth, Royal Papworth Hospital, UK

Trial

Phase 3, PROMIS

Conference

ATS 2022

19 May, 2022 12:29

Type 2 asthma managed by dupilumab, despite atopic comorbidities

Presented By

Prof. Theresa Guilbert, University of Cincinnati, OH, USA

Trial

Phase 3, Liberty Asthma VOYAGE

Conference

ATS 2022

18 May, 2022 12:06

NAVIGATOR steers asthma patients to tezepelumab

Presented By

Prof. Njira Lugogo, University of Michigan, MI, USA

Trial

Phase 3, NAVIGATOR

Conference

ATS 2022

18 May, 2022 12:05

No screening evidence for COPD

Presented By

Prof. Carol Mangione, University of California at Los Angeles, CA, USA

Conference

ATS 2022

18 May, 2022 12:04

COVI-PRONE trial on its back

Presented By

Prof. Waleed Alhazzani, McMaster University, Canada

Trial

COVI-PRONE

Conference

ATS 2022

18 May, 2022 12:02

High-intensity interval training slashes daily corticosteroids in asthma

Presented By

Dr Anders Pitzner-Fabricius, Rigshospitalet Copenhagen, Denmark

Conference

ATS 2022

18 May, 2022 12:00

Obstructive sleep apnoea in most kids with PH

Presented By

Prof. Daniel Ignatiuk, Cincinnati Children’s Hospital, OH, USA

Conference

ATS 2022

18 May, 2022 11:59

Novel PDE4B inhibitor offers breakthrough for IPF

Presented By

Prof. Luca Richeldi, Università Cattolica del Sacro Cuore, Italy

Trial

Phase 2

Conference

ATS 2022

17 May, 2022 11:54

MANDALA patterns success for albuterol-budesonide in asthma

Presented By

Prof. Alberto Papi, University of Ferrara, Italy

Trial

Phase 3, MANDALA

Conference

ATS 2022

17 May, 2022 11:52

SPRINTER still in the running?

Presented By

Dr Phillip Monk, Synairgen Research LtD, UK

Trial

Phase 3, SPRINTER

Conference

ATS 2022

17 May, 2022 11:50

Lung transplantation after COVID-19-associated ARDS

Presented By

Prof. G.R. Scott Budinger, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Conference

ATS 2022

17 May, 2022 11:49

Hydrocortisone does not help pre-term infants

Presented By

Prof. Namasivayam Ambalavanan, University of Alabama, AL, USA

Conference

ATS 2022

17 May, 2022 11:48

CPAP supports pulmonary oxygenation in morbidly obese patients

Presented By

Dr Felix Girrbach, University Hospital of Leipzig, Germany

Conference

ATS 2022

17 May, 2022 11:46